New hope for toddlers with bladder nerve damage: mirabegron trial launches
NCT ID NCT05621616
First seen Sep 30, 2025 · Last updated May 23, 2026 · Updated 34 times
Summary
This study tests a liquid form of mirabegron, a drug already approved for older children and adults, in children aged 6 months to 3 years who have bladder problems due to nerve damage (neurogenic detrusor overactivity). The goal is to see if the drug helps the bladder hold more urine safely, reducing leakage and pressure. Seven children will receive a daily dose for up to a year, with careful monitoring of safety and bladder function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROGENIC DETRUSOR OVERACTIVITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Site PH63001
Quezon, Philippines
-
Site PH63002
Quezon City, Philippines
-
Site PL48001
Gdansk, Poland
Conditions
Explore the condition pages connected to this study.